W. Rowlands
Director/Board Member bei A-LABS CAPITAL II CORP.
Aktive Positionen von W. Rowlands
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| A-LABS CAPITAL II CORP. | Director/Board Member | 05.09.2018 | - |
| Independent Dir/Board Member | 05.09.2018 | - |
Karriereverlauf von W. Rowlands
Ehemalige bekannte Positionen von W. Rowlands
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| XORTX THERAPEUTICS INC. | Director/Board Member | 09.01.2018 | 08.05.2018 |
| Chairman | 08.05.2018 | 20.12.2021 | |
| Independent Dir/Board Member | 09.01.2018 | 20.12.2021 | |
| Public Communications Contact | 09.01.2018 | 20.12.2021 | |
| TALISKER RESOURCES LTD. | Director/Board Member | 15.03.2018 | 26.09.2018 |
| Chief Executive Officer | 01.04.2006 | 15.03.2018 | |
| Chairman | 28.06.2012 | 15.03.2018 | |
| President | 01.04.2006 | 01.08.2014 | |
| APTOSE BIOSCIENCES INC. | Public Communications Contact | 01.01.2003 | 01.01.2005 |
| Dominick & Dominick Securities, Inc. | Director/Board Member | 01.01.1999 | 01.01.2003 |
| Corporate Officer/Principal | 01.01.1999 | 01.01.2003 | |
XORTX Pharma Corp.
 XORTX Pharma Corp. Pharmaceuticals: MajorHealth Technology XORTX Pharma Corp. engages in the discovery, development, and commercialization of therapies for rare diseases. It develops cardio-vascular medications for the treatment of rare diseases such as autosomal dominant polycystic kidney disease, hereditary hypouricemia, cystic fibrosis as well as large market diseases such as hypertension, metabolic syndrome, diabetes, and diabetic nephropathy. The company was founded in 2012 and is headquartered in Calgary, Canada. | Director/Board Member | 01.11.2014 | - |
Statistik
International
| Kanada | 7 |
Operativ
| Director/Board Member | 5 |
| Public Communications Contact | 2 |
| Chairman | 2 |
Sektoral
| Health Technology | 4 |
| Non-Energy Minerals | 2 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| APTOSE BIOSCIENCES INC. | Health Technology |
| TALISKER RESOURCES LTD. | Non-Energy Minerals |
| XORTX THERAPEUTICS INC. | Health Technology |
| A-LABS CAPITAL II CORP. | Finance |
| Private Unternehmen | 2 |
|---|---|
XORTX Pharma Corp.
XORTX Pharma Corp. Pharmaceuticals: MajorHealth Technology XORTX Pharma Corp. engages in the discovery, development, and commercialization of therapies for rare diseases. It develops cardio-vascular medications for the treatment of rare diseases such as autosomal dominant polycystic kidney disease, hereditary hypouricemia, cystic fibrosis as well as large market diseases such as hypertension, metabolic syndrome, diabetes, and diabetic nephropathy. The company was founded in 2012 and is headquartered in Calgary, Canada. | Health Technology |
| Dominick & Dominick Securities, Inc. |
- Börse
- Insiders
- W. Rowlands
- Erfahrung
